Literature DB >> 7450664

[Disparate efficacy of isosorbide dinitrate, in sustained-release form, during acute and chronic administration (author's transl)].

R Blasini, U Brügmann, A Mannes, K L Froer, D Hall, W Rudolph.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1980        PMID： 7450664

Source DB:  PubMed          Journal:  Herz        ISSN： 0340-9937            Impact factor:   1.443


× No keyword cloud information.
  7 in total

Review 1.  Mechanisms of nitrate tolerance: a review.

Authors:  R J Katz
Journal:  Cardiovasc Drugs Ther       Date:  1990-02       Impact factor: 3.727

Review 2.  Nitrates: why and how should they be used today? Current status of the clinical usefulness of nitroglycerin, isosorbide dinitrate and isosorbide-5-mononitrate.

Authors:  S Silber
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953

3.  The haemodynamic and anti-ischaemic effects of a single tablet of 80 mg isosorbide dinitrate in slow-release formulation and a review of nitrate tolerance.

Authors:  S Silber; A C Vogler; K H Krause; K Theisen
Journal:  Drugs       Date:  1987       Impact factor: 9.546

4.  Intra-individual comparison of the action of equal doses of isosorbide-5-endomononitrate, slow-release isosorbide dinitrate and placebo in patients with coronary heart disease.

Authors:  G Müller; W Häcker; B Schneider
Journal:  Klin Wochenschr       Date:  1983-04-15

Review 5.  Nitrate tolerance. A review of the evidence.

Authors:  J T Flaherty
Journal:  Drugs       Date:  1989-04       Impact factor: 9.546

Review 6.  Nonresponsiveness to antianginal therapy--a frequent problem?

Authors:  W Schulz
Journal:  Cardiovasc Drugs Ther       Date:  1988-05       Impact factor: 3.727

7.  [Anti-angina effectiveness of isosorbide dinitrate in an acute trial and following continuous 4-week therapy with 40 mg 6 times a day].

Authors:  W Schneider; A Wietschoreck; W D Bussmann; M Kaltenbach
Journal:  Klin Wochenschr       Date:  1985-05-15
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.